These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3280795)
1. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of auranofin: a review of clinical experience. Blodgett RC; Pietrusko RG Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943 [TBL] [Abstract][Full Text] [Related]
3. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751 [TBL] [Abstract][Full Text] [Related]
4. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832 [TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of auranofin: results of a randomized clinical trial. Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585 [TBL] [Abstract][Full Text] [Related]
6. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308 [TBL] [Abstract][Full Text] [Related]
7. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis? Bandilla K; Missler B; Klein-Reesink B Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777 [TBL] [Abstract][Full Text] [Related]
8. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine. Leonard PA; Bienz SR; Clegg DO; Ward JR J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632 [TBL] [Abstract][Full Text] [Related]
9. Auranofin therapy in juvenile rheumatoid arthritis: a 48-week phase II study. Kvien TK; Høyeraal HM; Sandstad B; Kass E Scand J Rheumatol Suppl; 1986; 63():79-83. PubMed ID: 3474778 [TBL] [Abstract][Full Text] [Related]
10. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
11. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
12. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study]. Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087 [TBL] [Abstract][Full Text] [Related]
13. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study. Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682 [TBL] [Abstract][Full Text] [Related]
15. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin]. Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
17. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose. Bernhard GC J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477 [TBL] [Abstract][Full Text] [Related]
18. Postmarketing experience with auranofin in the Federal Republic of Germany. Schattenkirchner M; Missler B; Mulz D Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503 [TBL] [Abstract][Full Text] [Related]
20. Incidence and management of diarrhea during longterm auranofin therapy. Wallin BA; McCafferty JP; Fox MJ; Cooper DR; Goldschmidt MS J Rheumatol; 1988 Dec; 15(12):1755-8. PubMed ID: 3265956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]